Decoy Therapeutics Inc. (DCOY) Stock
Decoy Therapeutics stock price chart
DCOY stock quote & key statistics
Decoy Therapeutics annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0 | -$12.5M | $19.90 |
| FY2024 | $0 | -$5.6M | -$4141.01 |
| FY2023 | $0 | -$12.5M | -$6528.81 |
| FY2022 | $0 | -$31.6M | -$15542.51 |
| FY2021 | $1.8M | -$12.8M | -$7560.09 |
Fiscal year ending December 31. Source: company filings via EODHD.
About Decoy Therapeutics Inc.
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company's IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting various unmet medical needs.
It focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Houston, Texas.
Decoy Therapeutics stock FAQ
What is the Decoy Therapeutics stock ticker symbol?
Decoy Therapeutics Inc. trades on the NASDAQ under the ticker symbol DCOY.
What sector and industry is Decoy Therapeutics in?
Decoy Therapeutics Inc. is classified in the Healthcare sector, Biotechnology industry.
How many employees does Decoy Therapeutics have?
Decoy Therapeutics Inc. has about 11 full-time employees.
What were Decoy Therapeutics's revenue and earnings last fiscal year?
Decoy Therapeutics reported revenue of $0 and net income of -$12.5M in fiscal 2025, with earnings per share of $19.90.
When did Decoy Therapeutics go public?
Decoy Therapeutics stock began trading on January 7, 2026.
Biotechnology stocks
All Healthcare stocks →- ACADACADIA Pharmaceuticals
- ALNYAlnylam
- ARWRArrowhead Pharmaceuticals
- ASNDAscendis Pharma A/S
- BMRNBioMarin Pharmaceutical
- CAICaris Life Sciences
- CORTCorcept Therapeutics
- EXELExelixis
- FTREFortrea
- HALOHalozyme Therapeutics
- HRMYHarmony Biosciences
- INCYIncyte
- IONSIonis Pharmaceuticals
- JAZZJazz Pharmaceuticals
- MDGLMadrigal Pharmaceuticals
- MRNAModerna
- NVAXNovavax
- PTCTPTC Therapeutics
- RAREUltragenyx Pharmaceutical
- REGNRegeneron
- RPRXRoyalty Pharma
- SRPTSarepta Therapeutics
- TECHBio-Techne
- VRTXVertex